Citrate-Buffered Dialysis Solution (Citrasate) Allows Avoidance of Anticoagulation During Intermittent Hemodiafiltration-At the Cost of Decreased Performance and Systemic Biocompatibility

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11140%2F17%3A10362916" target="_blank" >RIV/00216208:11140/17:10362916 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1111/aor.12851" target="_blank" >http://dx.doi.org/10.1111/aor.12851</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1111/aor.12851" target="_blank" >10.1111/aor.12851</a>

Result language
angličtina
Original language name
Citrate-Buffered Dialysis Solution (Citrasate) Allows Avoidance of Anticoagulation During Intermittent Hemodiafiltration-At the Cost of Decreased Performance and Systemic Biocompatibility
Original language description
Comparison of citrate- (without anticoagulation) and acetate-based (with anticoagulation) dialysis solution from the view of short-term safety, efficacy and biocompatibility in patients from long-term hemodialysis program. Clinical study.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30217 - Urology and nephrology

Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)